| A pragmatic–explanatory continuum indicator summary (PRECIS): a tool to help trial designers KE Thorpe, M Zwarenstein, AD Oxman, S Treweek, CD Furberg, ... Journal of clinical epidemiology 62 (5), 464-475, 2009 | 1231 | 2009 |
| Upregulation and nuclear recruitment of HDAC1 in hormone refractory prostate cancer K Halkidou, L Gaughan, S Cook, HY Leung, DE Neal, CN Robson The Prostate 59 (2), 177-189, 2004 | 554 | 2004 |
| Evidence for overuse of medical services around the world S Brownlee, K Chalkidou, J Doust, AG Elshaug, P Glasziou, I Heath, ... The Lancet 390 (10090), 156-168, 2017 | 334 | 2017 |
| Expression of Tip60, an androgen receptor coactivator, and its role in prostate cancer development K Halkidou, VJ Gnanapragasam, PB Mehta, IR Logan, ME Brady, S Cook, ... Oncogene 22 (16), 2466-2477, 2003 | 236 | 2003 |
| How to formulate research recommendations P Brown, K Brunnhuber, K Chalkidou, I Chalmers, M Clarke, M Fenton, ... Bmj 333 (7572), 804-806, 2006 | 188 | 2006 |
| Comparative effectiveness research and evidence‐based health policy: experience from four countries K Chalkidou, S Tunis, R Lopert, L Rochaix, PT Sawicki, M Nasser, B Xerri The Milbank Quarterly 87 (2), 339-367, 2009 | 175 | 2009 |
| The role for pragmatic randomized controlled trials (pRCTs) in comparative effectiveness research K Chalkidou, S Tunis, D Whicher, R Fowler, M Zwarenstein Clinical trials 9 (4), 436-446, 2012 | 135 | 2012 |
| Evidence-informed frameworks for cost-effective cancer care and prevention in low, middle, and high-income countries K Chalkidou, P Marquez, PK Dhillon, Y Teerawattananon, ... The lancet oncology 15 (3), e119-e131, 2014 | 118 | 2014 |
| Searching for cost effectiveness thresholds in the NHS J Appleby, N Devlin, D Parkin, M Buxton, K Chalkidou Health policy 91 (3), 239-245, 2009 | 113 | 2009 |
| Social values in health priority setting: a conceptual framework P Littlejohns, A Weale, K Chalkidou, Y Teerwattananon, R Faden, S Clark Journal of health organization and management, 2012 | 112 | 2012 |
| NCD Countdown 2030: worldwide trends in non-communicable disease mortality and progress towards Sustainable Development Goal target 3.4 JE Bennett, GA Stevens, CD Mathers, R Bonita, J Rehm, ME Kruk, ... The Lancet 392 (10152), 1072-1088, 2018 | 109 | 2018 |
| Priority-setting in health: building institutions for smarter public spending A Glassman, K Chalkidou Washington, DC: Center for Global Development, 2012 | 103 | 2012 |
| Evidence-based decision making: when should we wait for more information? K Chalkidou, J Lord, A Fischer, P Littlejohns Health Affairs 27 (6), 1642-1653, 2008 | 86 | 2008 |
| Priority-setting institutions in health: recommendations from a center for global development working group A Glassman, K Chalkidou, U Giedion, Y Teerawattananon, S Tunis, ... Global Heart 7 (1), 13-34, 2012 | 72 | 2012 |
| Making a decision to wait for more evidence: when the National Institute for Health and Clinical Excellence recommends a technology only in the context of research K Chalkidou, A Hoy, P Littlejohns Journal of the Royal Society of Medicine 100 (10), 453-460, 2007 | 71 | 2007 |
| Nuclear accumulation of histone deacetylase 4 (HDAC4) coincides with the loss of androgen sensitivity in hormone refractory cancer of the prostate K Halkidou, S Cook, HY Leung, DE Neal, CN Robson European urology 45 (3), 382-389, 2004 | 69 | 2004 |
| Priority-setting for achieving universal health coverage K Chalkidou, A Glassman, R Marten, J Vega, Y Teerawattananon, ... Bulletin of the World Health Organization 94 (6), 462, 2016 | 62 | 2016 |
| Expensive cancer drugs: a comparison between the United States and the United Kingdom RR Faden, K Chalkidou, J Appleby, HR Waters, JP Leider The Milbank Quarterly 87 (4), 789-819, 2009 | 54 | 2009 |
| Putative involvement of the histone acetyltransferase Tip60 in ribosomal gene transcription K Halkidou, IR Logan, S Cook, DE Neal, CN Robson Nucleic acids research 32 (5), 1654-1665, 2004 | 53 | 2004 |
| Cost‐effective public health guidance: asking questions from the decision‐maker's viewpoint K Chalkidou, A Culyer, B Naidoo, P Littlejohns Health economics 17 (3), 441-448, 2008 | 52 | 2008 |
Anthony J CulyerUniversity of YorkVerifierad e-postadress på york.ac.uk
